Prostate Cancer Research - Symptoms, Genetics, Screening, Treatment, Information

Prostate Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Prostate Cancer, including details on symptoms, genetics, screening, treatment, information.


Prostate Cancer Research Today

Home

View Latest Issue

Information About Prostate Cancer

Books on Prostate Cancer

Advertising in Research Today

View Other Research Today Publications



Volume 1 (2004), Issue 2 (September)

  1. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer.
    Int J Cancer, 112(2): 335-40. [Abstract] [Full-text]
  2. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs.
    Int J Cancer, 112(2): 231-8. [Abstract] [Full-text]
  3. Expression of transforming growth factor-beta 1 and growth in soft agar differentiate prostate carcinoma-associated fibroblasts from normal prostate fibroblasts.
    Int J Cancer, 112(2): 213-8. [Abstract] [Full-text]
  4. CYP1B1 expression in prostate is higher in the peripheral than in the transition zone.
    Cancer Lett, 215(1): 69-78. [Abstract] [Full-text]
  5. Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters.
    Prostate, 61(3): 201-8. [Abstract] [Full-text]
  6. Prostasomes are secreted from poorly differentiated cells of prostate cancer metastases.
    Prostate, 61(3): 291-7. [Abstract] [Full-text]
  7. Restoration of fibroblast growth factor receptor2 suppresses growth and tumorigenicity of malignant human prostate carcinoma PC-3 cells.
    Prostate, 61(3): 236-42. [Abstract] [Full-text]
  8. CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenografts.
    Prostate, 61(3): 228-35. [Abstract] [Full-text]
  9. Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarrays.
    Prostate, 61(3): 215-27. [Abstract] [Full-text]
  10. Trefoil factor 3 is overexpressed in human prostate cancer.
    Prostate, 61(3): 209-14. [Abstract] [Full-text]
  11. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
    Prostate, 61(3): 276-90. [Abstract] [Full-text]
  12. Vitamin D receptor gene polymorphisms and disease free survival after radical prostatectomy.
    Prostate, 61(3): 267-75. [Abstract] [Full-text]
  13. Lesions predictive for prostate cancer in a screened population: first and second screening round findings.
    Prostate, 61(3): 260-6. [Abstract] [Full-text]
  14. Inhibitory effect of IL-6-induced neuroendocrine cells on prostate cancer cell proliferation.
    Prostate, 61(3): 253-9. [Abstract] [Full-text]
  15. HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.
    Prostate, 61(3): 248-52. [Abstract] [Full-text]
  16. Epothilone induced cytotoxicity is dependent on p53 status in prostate cells.
    Prostate, 61(3): 243-7. [Abstract] [Full-text]
  17. Glycemic index, glycemic load and risk of prostate cancer.
    Int J Cancer, 112(3): 446-50. [Abstract] [Full-text]
  18. A novel DNA methyltransferase I-derived peptide eluted from soluble HLA-A*0201 induces peptide-specific, tumor-directed cytotoxic T cells.
    Int J Cancer, 112(3): 426-32. [Abstract] [Full-text]
  19. Binding and interstitial penetration of liposomes within avascular tumor spheroids.
    Int J Cancer, 112(4): 713-21. [Abstract] [Full-text]
  20. Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells.
    Int J Cancer, 112(4): 693-700. [Abstract] [Full-text]
  21. Retinol, carotenoids and the risk of prostate cancer: a case-control study from Italy.
    Int J Cancer, 112(4): 689-92. [Abstract] [Full-text]
  22. Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer.
    Cancer Immunol Immunother, 53(11): 995-1004. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Prostate Cancer Research Today. All Rights Reserved.



Prostate Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)



Prostate Cancer Books

The ABC's of Prostate Cancer: The Book That Could Save Your Life

The ABC's of Prostate Cancer: The Book That Could Save Your Life